186 related articles for article (PubMed ID: 10674422)
1. Memory and mental status correlates of modified Braak staging.
Grober E; Dickson D; Sliwinski MJ; Buschke H; Katz M; Crystal H; Lipton RB
Neurobiol Aging; 1999; 20(6):573-9. PubMed ID: 10674422
[TBL] [Abstract][Full Text] [Related]
2. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
[TBL] [Abstract][Full Text] [Related]
3. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
4. The Free and Cued Selective Reminding Test Predicts Braak Stage.
Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
J Alzheimers Dis; 2021; 80(1):175-183. PubMed ID: 33492287
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.
Ehrenberg AJ; Suemoto CK; França Resende EP; Petersen C; Leite REP; Rodriguez RD; Ferretti-Rebustini REL; You M; Oh J; Nitrini R; Pasqualucci CA; Jacob-Filho W; Kramer JH; Gatchel JR; Grinberg LT
J Alzheimers Dis; 2018; 66(1):115-126. PubMed ID: 30223398
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
[TBL] [Abstract][Full Text] [Related]
7. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
8. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
9. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
Merlini M; Wanner D; Nitsch RM
Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.
Gosche KM; Mortimer JA; Smith CD; Markesbery WR; Snowdon DA
Neurology; 2002 May; 58(10):1476-82. PubMed ID: 12034782
[TBL] [Abstract][Full Text] [Related]
11. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging.
Brown DF; Risser RC; Bigio EH; Tripp P; Stiegler A; Welch E; Eagan KP; Hladik CL; White CL
J Neuropathol Exp Neurol; 1998 Oct; 57(10):955-60. PubMed ID: 9786245
[TBL] [Abstract][Full Text] [Related]
12. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
13. Clinical validity of Braak neuropathological staging in the oldest-old.
Gold G; Bouras C; Kövari E; Canuto A; Glaría BG; Malky A; Hof PR; Michel JP; Giannakopoulos P
Acta Neuropathol; 2000 May; 99(5):579-82; discussion 583-4. PubMed ID: 10805104
[TBL] [Abstract][Full Text] [Related]
14. Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.
Carter TL; Rissman RA; Mishizen-Eberz AJ; Wolfe BB; Hamilton RL; Gandy S; Armstrong DM
Exp Neurol; 2004 Jun; 187(2):299-309. PubMed ID: 15144856
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impact of subcortical vascular and Alzheimer's disease pathology.
Chui HC; Zarow C; Mack WJ; Ellis WG; Zheng L; Jagust WJ; Mungas D; Reed BR; Kramer JH; Decarli CC; Weiner MW; Vinters HV
Ann Neurol; 2006 Dec; 60(6):677-87. PubMed ID: 17192928
[TBL] [Abstract][Full Text] [Related]
17. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.
Samuel W; Galasko D; Masliah E; Hansen LA
J Neuropathol Exp Neurol; 1996 Jan; 55(1):44-52. PubMed ID: 8558171
[TBL] [Abstract][Full Text] [Related]
18. Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?
Crum J; Wilson J; Sabbagh M
Alzheimers Res Ther; 2018 Oct; 10(1):104. PubMed ID: 30285877
[TBL] [Abstract][Full Text] [Related]
19. Implicit memory and Alzheimer's disease neuropathology.
Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
[TBL] [Abstract][Full Text] [Related]
20. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
